Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 3/20 | 0.34 |
| ▸ | AR | P10275 | 5/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PLA2G7 | Q13093 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3945504 | 0.96 | TRPV4 (0.36) | TRPV4ARCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL3945510 | 0.90 | TRPV4 (0.36) | TRPV4ARCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13032025 | 0.88 | TRPV4 (0.37) | TRPV4 | |
| SCHEMBL3950721 | 0.86 | TRPV4 (0.36) | TRPV4ARCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL12979831 | 0.85 | AR (0.34) | TRPV4ARPLA2G7 | |
| Trifluoroacetic Acid SCHEMBL3950454 | 0.85 | TRPV4 (0.35) | TRPV4 | |
| Trifluoroacetic Acid SCHEMBL3480227 | 0.83 | TRPV4 (0.31) | TRPV4 | |
| Trifluoroacetic Acid SCHEMBL3939875 | 0.83 | TRPV4 (0.36) | TRPV4 | |
| Trifluoroacetic Acid SCHEMBL3948690 | 0.82 | PLA2G7 (0.34) | TRPV4ARPLA2G7 | |
| SCHEMBL13032111 | 0.82 | AR (0.34) | TRPV4ARCYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049200-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | MethylGene Inc. (CA) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008073142-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK & CO., INC. (US) | 2008-06-19 | — | — | WO | disclosed |